The Global Cardiac Rehabilitation Market size is expected to reach $2.4 billion by 2028, rising at a market growth of 5.3% CAGR during the forecast period.
Cardiac rehabilitation consists of three equally significant components, such as stress management counselling, information about healthy heart living, and exercise counselling and training. Cardiovascular rehabilitation aids in locating common stressors. The best aspect of recovery after a heart attack or other heart condition is cardiac rehabilitation. It can aid in the development of heart-healthy behaviours and helps to prevent major heart attacks.
Cardiac rehabilitation provides several health advantages, including alleviating heart disease symptoms like chest discomfort and reducing further illness and heart disease-related fatalities. Programs for cardiac rehabilitation concentrate on blood pressure control, diabetes control, exercise instruction, and physical activity guidance. Cardiac rehabilitation improves quality of life while lowering medical expenses.
One of the key elements driving the growth of the cardiac rehabilitation market is the rise in popularity of e-cardiology and e-health. Additionally, the industry has developed new strategies and partnerships thanks to the medical device sector in order to meet the pandemic's urgent needs. For instance, more than 868,000 Americans died from heart disease in 2022, while more than 34.2 people per 100,000 total population perished from diabetes, according to statistics examined on January 10 by the Centers for Disease Control and Prevention.
As a result, the prevalence of cardiovascular disorders is rising, which raises the demand for handheld monitoring devices and is expected to support the market for cardiac rehabilitation. Among the key market trends for cardiac rehabilitation include a rise in government funding for the management of heart disorders and an increased demand for efficient preventative measures. Additional major competitors that contribute to the market's expansion are Baxter International Inc., Philips N.V., Smits Group, and Life Fitness. These companies offer cardiac rehabilitation equipment.
Patients with COVID-19 had a higher prevalence of cardiovascular disease, with myocardial damage being the most prevalent diagnosis. Therefore, a broad range of cardiovascular disorders were prevalent among patients with COVD-19, leading to an increase in the demand for the use of cardiac rehabilitation equipment. These are some of the main drivers of the market's expansion and the need for cardiac rehabilitation programs. For instance, In Body, a leader in body composition technology who has launched the BP 170 blood pressure device in February 2022, gives people the choice to track and self-record important health data at home.
The market for cardiac rehabilitation is reportedly being driven by an increase in the elderly population and the corresponding rise in cardiovascular disorders. The development of the cardiac rehabilitation market is further fueled by the infrastructural improvements done in numerous healthcare sectors across different nations. Along with this, there has been an increase in government initiatives to address issues like the difficulty in finding equipment and gadgets at reasonable rates and the incidence of certain cardiovascular diseases.
Old habits are difficult to break, but poor food habits and a sedentary lifestyle may exacerbate heart issues. Cardiovascular disease, which arises as a result of unhealthy weight, inadequate stress management, and smoking, accounts for about a significant percentage of all fatalities worldwide. Cardiovascular rehabilitation shows patients how to manage such risk factors and enhance their long-term heart health. There are many people who are adopting active lifestyle and are visiting cardiac rehabilitation centers to improve their heart health.
The difficulty in obtaining Cardiac Rehabilitation devices & equipment from the numerous hospitals and clinics is the market's main issue. Despite the market for cardiac rehabilitation having had significant expansion, it is anticipated that these characteristics, together with the high cost of installing the equipment and technologies used in cardiac rehabilitation, would provide challenges to the market. Along with that, there are many rehab centers which do not have enough budget to deploy better and advanced equipment range.
Based on product, the cardiac rehabilitation market is segmented into Elliptical Trainer, Stabilization ball, Treadmill, Heart rate monitor, Blood pressure monitor, Rower and Others. The blood pressure monitor segment acquired a significant revenue share in the cardiac rehabilitation market in 2021. It is due to the growing demand for maintaining physical fitness. Anyone who requires or wants to measure their blood pressure at home, even those with hypertension, can benefit from having a reliable home blood pressure monitor.
By disease type, the cardiac rehabilitation market is classified into Percutaneous Coronary Intervention, Myocardial Infarction, Coronary Artery Bypass Grafting, Coronary Artery Disease and Others. The Percutaneous Coronary Intervention (PCI) segment procured a significant revenue share in cardiac rehabilitation market in 2021. It is due to increase in obstructive coronary artery disease cases in the general population. A small incision is made in the wrist or upper thigh during a PCI procedure, and a catheter a thin, flexible tube is then inserted via an artery leading to the heart to enter the blocked channel.
On the basis of end-user, the cardiac rehabilitation market is divided into Rehab Centers, Hospitals, Clinics and Others. The rehab centers segment recorded the maximum revenue share in the cardiac rehabilitation market in 2021. It is due to an increase in health consciousness among individuals and a boost in the number of rehabilitation facilities offering rehabilitation therapies in both emerging and developed economies. This trend is anticipated to continue over the forecast period.
Report Attribute | Details |
---|---|
Market size value in 2021 | USD 1.7 Billion |
Market size forecast in 2028 | USD 2.4 Billion |
Base Year | 2021 |
Historical Period | 2018 to 2020 |
Forecast Period | 2022 to 2028 |
Revenue Growth Rate | CAGR of 5.3% from 2022 to 2028 |
Number of Pages | 265 |
Number of Tables | 420 |
Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling |
Segments covered | Product, Disease Type, End User, Region |
Country scope | US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria |
Growth Drivers |
|
Restraints |
|
Free Valuable Insights: Global Cardiac Rehabilitation Market size to reach USD 2.4 Billion by 2028
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Technogym S.p.A., Johnson Health Tech. Co., Ltd., Omron Corporation, Koninklijke Philips N.V., Baxter International, Inc., Halma PLC, ICU Medical, Inc. (Smiths Medical), General Electric (GE) Co. (GE Healthcare), Life Fitness, and Core Health & Fitness, LLC.
By Product
By End User
By Disease Type
By Geography
The global Cardiac Rehabilitation Market size is expected to reach $2.4 billion by 2028.
Increasing Geriatric Population And Growing Incidences Of Numerous Cardiovascular Diseases are driving the market in coming years, however, Cost Of Cardiac Rehabilitation Equipment Has Increased which restraints the growth of the market.
Technogym S.p.A., Johnson Health Tech. Co., Ltd., Omron Corporation, Koninklijke Philips N.V., Baxter International, Inc., Halma PLC, ICU Medical, Inc. (Smiths Medical), General Electric (GE) Co. (GE Healthcare), Life Fitness, and Core Health & Fitness, LLC.
The expected CAGR of the Cardiac Rehabilitation Market is 5.3% from 2022 to 2028.
The Treadmill segment acquired maximum revenue share in the Global Cardiac Rehabilitation Market by Product in 2021 thereby, achieving a market value of $628.8 Million by 2028.
The North America market dominated the Global Cardiac Rehabilitation Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $855.1 Million by 2028.
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.